92P Neoadjuvant multimodality RX including immunotherapy for highly selective unresectable locally advanced esophageal squamous cell carcinoma (NEXUS): A prospective, single-arm, phase II trial

X. Wang,X. Chen, X. Kang, R. Zhang, D. Qu, L. Xue, G. Cheng, G. Xi, T. Zhang, L. Deng,W. Liu,N. Bi,Y. Li

Immuno-Oncology and Technology（2022）

引用 0|浏览9

暂无评分

关键词

squamous cell carcinoma,neoadjuvant multimodality rx,cell carcinoma,immunotherapy,single-arm

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要